Selenium is a trace element required for normal functioning of all organisms. Saccharomyces cerevisiae yeast can convert more than 99% of inorganic selenium into its safest, bioavailable organically complexed food forms. Supplementation with selenium yeast may prevent some forms of cancer, and support immunity, thyroid, brain health and fertility.
BUSINESS NEWS
05 Apr 2024 --- This week in nutrition news, the World Health Organization (WHO) launched an artificial intelligence (AI) powered health tool. Meanwhile, the Infant Nutrition Council of America (INCA) spotlighted the global... Read More
FOOD INGREDIENTS NEWS
Spotlight on sodium: Food innovators embrace the challenge of balancing taste and health
13 Mar 2024 --- In a time marked by heightened consumer consciousness surrounding health and wellness, the food manufacturing industry grapples with a pressing dilemma: meeting the demand for healthier dietary options while... Read More
BUSINESS NEWS
05 Mar 2024 --- February’s major health and nutrition news included the climate threats to wheat production, research on the effect of deep space on astronauts’ microbiomes, an interview with the creator of the... Read More
NUTRITION & HEALTH NEWS
Pioneering the future of nutrition: Lallemand Health Solutions’ tech-driven approach
05 Feb 2024 --- Digitalization, next-generation technologies and scientific advancements are set to shake up the supplement and nutraceutical industry in the coming years. Companies are increasingly utilizing modern tech to... Read More
BUSINESS NEWS
Lallemand Bio-Ingredients president unravels opportunities in Evolva acquisition
26 Jan 2024 --- Lallemand Bio-Ingredients’ recent acquisition of Swiss biotechnology firm Evolva for a reported CHF20 million (∼US$23 million) will enable the company to produce complex molecules from yeast for the... Read More
Lallemand: Bio-Ingredients president sheds light on Evolva acquisition
23 Jan 2024 --- Lallemand Bio-Ingredients president and general manager Lars Asferg unravels the potential in the company’s recent acquisition of Swiss biotechnology firm Evolva. Asferg discusses how Evolva’s precision fermentation tech could boost Lallemand’s health and flavor and fragrance businesses. He also outlines the business unit’s key focuses for 2024.
Lallemand Health Solutions unveils innovations in probiotics and texture
29 Aug 2023 --- Bérengère Feuz, Lallemand Health Solutions’ marketing and technical support director, highlights the benefits of the company’s S. boulardii, the first certified organic version of this probiotic. She also shares recent company innovations that offer increased convenience, such as its gummy with a dual-textured option, where manufacturers can add pro- and postbiotics.
CPHI Frankfurt 2022: Lallemand Health Solutions delves into probiotic potentials and solutions
17 Nov 2022 --- Alan Gonzalez, area sales manager at Lallemand Health Solutions, tells NutritionInsight about the company’s “outside-the-box” probiotic solutions and innovations. It touts the scientific evidence showing that its probiotic products could help to relieve symptoms of Irritable Bowel Syndrome, improve mood, relieve anxiety and restore gut health.
HS2-free lager yeast hybrid, organic certified nutrient for sugar fermentation
31 Oct 2022 --- Tobias Fischborn talks through the launch of an HS2-free lager yeast hybrid and a new nutrient based on yeast extracts which is organic certified and mainly developed for sugar fermentation of hard seltzer to give a cleaner flavor compared to chemical solutions.
Vitafoods Europe 2022: Lallemand spotlights probiotics for women’s health
04 Oct 2022 --- As research on probiotics expands, Lallemand Health Solutions highlights the importance of convenience for women’s intimate health. The company’s marketing director Bérengère Feuz explains how utilizing an oral intake probiotic helps with compliance and regular use, especially when compared to local applications.
Gastro-AD® fermented soy for gastrointestinal health
11 Nov 2021 --- Gastro-AD® is a food supplement based on non-GMO soy fermented by Lactobacillus strain L delbrueckii R-187 (Rosell-187). It has an excellent track record of safe and effective use for management of symptoms of GERD including acid reflux, heartburn, vomiting, and nausea and has been backed by several published studies, in over 600 people. Gastro-AD® represents a natural and safe alternative to over-the-counter (OTC) remedies with the extra nutritional benefits of fermented soy. The latest Gastro-AD® clinical trial was published in 2020.